Development of CDK2 and CDK5 Dual Degrader TMX-2172

Cyclin-dependent kinase 2 (CDK2) is a potential therapeutic target for the treatment of cancer. Development of CDK2 inhibitors has been extremely challenging as its ATP-binding site shares high similarity with CDK1, a related kinase whose inhibition causes toxic effects. Here, we report the developm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Angew Chem Int Ed Engl
Autori principali: Teng, Mingxing, Jiang, Jie, He, Zhixiang, Kwiatkowski, Nicholas P., Donovan, Katherine A., Mills, Caitlin E., Victor, Chiara, Hatcher, John M., Fischer, Eric S., Sorger, Peter K., Zhang, Tinghu, Gray, Nathanael S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7703486/
https://ncbi.nlm.nih.gov/pubmed/32415712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.202004087
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi